Chemtrade Q3 2026 adjusted EBITDA falls to $145.1 million

PUBT · 11h ago
Chemtrade Q3 2026 adjusted EBITDA falls to $145.1 million
  • Chemtrade's third-quarter 2026 adjusted EBITDA fell to $145.1 million year-over-year on lower chlor-alkali selling prices and sodium chlorate volumes.
  • Unitholders will vote December 7 on a proposed conversion from an income trust to a corporation, intended to broaden its investor base.
  • The fund tightened its 2026 adjusted EBITDA guidance to $495 million–$515 million, largely in line with expectations issued at the year's start.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemtrade Logistics Income Fund published the original content used to generate this news brief via Business Wire (Ref. ID: 20261113330330) on November 13, 2026, and is solely responsible for the information contained therein.